BR0307021A - Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários - Google Patents

Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários

Info

Publication number
BR0307021A
BR0307021A BR0307021-2A BR0307021A BR0307021A BR 0307021 A BR0307021 A BR 0307021A BR 0307021 A BR0307021 A BR 0307021A BR 0307021 A BR0307021 A BR 0307021A
Authority
BR
Brazil
Prior art keywords
preventive treatment
alkylphosphocholines
protozoan diseases
diseases
protozoan
Prior art date
Application number
BR0307021-2A
Other languages
English (en)
Inventor
Juergen Engel
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of BR0307021A publication Critical patent/BR0307021A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE ALQUILFOSFOCOLINAS NO TRATAMENTO PREVENTIVO DE DOENçAS DE PROTOZOáRIOS". A presente invenção refere-se a composições farmacêuticas contendo alquilfosfocolinas, especialmente hexadecilfosfocolina ou 1,1-dimetilpiperidino-4-il fosfato de octadecila para o tratamento preventivo de doenças de protozoários, especialmente leishmaniose. A presente invenção também refere-se a um esquema de dosagem das ditas composições para o tratamento preventivo das ditas doenças.
BR0307021-2A 2002-01-25 2003-01-07 Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários BR0307021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (de) 2002-01-25 2002-01-25 Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen
PCT/EP2003/000072 WO2003061669A1 (de) 2002-01-25 2003-01-07 Verwendung von alkylphosphocholinen in der präventivbehandlung von protozoenerkrankungen

Publications (1)

Publication Number Publication Date
BR0307021A true BR0307021A (pt) 2004-11-03

Family

ID=7713213

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307021-2A BR0307021A (pt) 2002-01-25 2003-01-07 Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários

Country Status (16)

Country Link
EP (1) EP1467742A1 (pt)
JP (1) JP2005515244A (pt)
CN (1) CN1622811A (pt)
AR (1) AR038224A1 (pt)
AU (1) AU2003236787B2 (pt)
BR (1) BR0307021A (pt)
CA (1) CA2470185A1 (pt)
CO (1) CO5601024A2 (pt)
DE (1) DE10203195A1 (pt)
IL (2) IL162492A0 (pt)
MX (1) MXPA04007193A (pt)
NZ (1) NZ548040A (pt)
PE (1) PE20030732A1 (pt)
TW (1) TWI339582B (pt)
WO (1) WO2003061669A1 (pt)
ZA (1) ZA200404690B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (de) * 2005-02-23 2007-10-15 Obwaller Andreas Dr Reinigungsmittel für kontaktlinsen
AR058397A1 (es) * 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
CA2131024A1 (en) * 1992-03-06 1993-09-16 Arsalan Kharazmi Treatment and prophylaxis of diseases caused by parasites, or bacteria
HUP0004363A3 (en) * 1998-01-22 2002-12-28 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis
DE10020812C2 (de) * 2000-04-20 2003-06-26 Robert Koch Inst Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika
AU2002232400A1 (en) * 2000-11-06 2002-05-15 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
AU2003236787B2 (en) 2007-03-22
CO5601024A2 (es) 2006-01-31
TW200302103A (en) 2003-08-01
EP1467742A1 (de) 2004-10-20
WO2003061669A1 (de) 2003-07-31
NZ548040A (en) 2007-06-29
JP2005515244A (ja) 2005-05-26
PE20030732A1 (es) 2003-09-27
AR038224A1 (es) 2005-01-05
TWI339582B (en) 2011-04-01
IL162492A0 (en) 2005-11-20
CN1622811A (zh) 2005-06-01
IL162492A (en) 2009-12-24
CA2470185A1 (en) 2003-07-31
ZA200404690B (en) 2004-09-27
MXPA04007193A (es) 2004-10-29
DE10203195A1 (de) 2003-08-07

Similar Documents

Publication Publication Date Title
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BR0213358A (pt) Uso de flibanserina
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR0016058A (pt) Compostos de fosfonato
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
TR200101103T2 (tr) CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
BG104727A (en) Pharmaceutical composition of topiramate
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
BG100911A (en) Biophosphonic acids-sontaining wet-granulated form
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
BR0307021A (pt) Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários
BR0213317A (pt) Uso de um composto, método de tratar um distúrbio relacionado com gastrina, composição farmacêutica, kit, usos de uma composição, e de um inibidor de bomba de próton, métodos de preparar uma composição farmacêutica e um composto, e, composto
IS4392A (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
BR0215336A (pt) Utilização de um composto ou um sal farmaceuticamente aceitável do mesmo, composto, e composição farmacêutica
ES2192018T3 (es) Composicion farmaceutica que contiene estimuladores de interferon-gamma.
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
BR9807271A (pt) Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: ZENTARIS GMBH (DE)

Free format text: SEDE ALTERADA CONFORME PETICAO NO 020060058923-RJ DE 27.04.2006.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL